• Nasal Spray Blunts Traumatic Brain Injury

  • Mar 11 2025
  • Durée: 1 min
  • Podcast

Nasal Spray Blunts Traumatic Brain Injury

  • Résumé


  • Vidcast: https://www.instagram.com/reel/DHD28nmuKit/


    So say neurologists at Harvard’s Brigham and Women’s Hospital. In a mouse model, they show that a nasal spray containing an anti-CD3 monoclonal antibody significantly reduces brain inflammation and speeds recovery after a traumatic brain injury (TBI).


    This antibody, sprayed into the nasal cavities, activates regulatory T cells, Tregs, that then travel to the brain and release IL-10 that in turn reduces microglial-medial inflammation there.


    This anti-CD3 nasal spray must still prove its effectiveness in humans. If so, it will become a treatment for the TBI that follows concussions, motor vehicle accidents, and other sports-related head trauma.


    https://www.nature.com/articles/s41593-025-01877-7


    #traumaticbraininjury #tbi #sports #cd3 #treg #il10 #mva #nasalspray

    Voir plus Voir moins

Ce que les auditeurs disent de Nasal Spray Blunts Traumatic Brain Injury

Moyenne des évaluations de clients

Évaluations – Cliquez sur les onglets pour changer la source des évaluations.